\-\ Texto\\:\\ \ \(0\)\
\-\ obtunded\\ \\-\\ but\\ with\\ no\\ focal\\ neurological\\ signs\\ or\\ symptoms\ \(0\)\
\-\ \\â\\€\\¢\\ abnormal\\ white\\ matter\\ signal\\ intensity\\ \\(t2w\\ and\\ flair\\)\\ in\\ the\\ posterior\\ frontal\\ and\\ parietal\\ lobes\\ \\-\\ vasogenic\\ edema\\?\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ mass\\ effect\\ or\\ hemorrhage\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ no\\ restricted\\ diffusion\\.\ \(0\)\
\-\ posterior\\ reversible\\ encephalopathy\\ syndrome\ \(0\)\
\-\ \\â\\€\\¢\\ autoimmune\\ vasculitis\ \(0\)\
\-\ \\â\\€\\¢\\ posterior\\ reversible\\ encephalopathy\\ syndrome\\ \\(pres\\)\ \(0\)\
\-\ \\â\\€\\¢\\ stroke\ \(0\)\
\-\ \\â\\€\\¢\\ viral\\ encephalitis\\ \ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ 49\\ year\\ old\\ woman\\,\\ with\\ lupus\\,\\ presents\\ with\\ a\\ first\\ time\\ seizure\\.\ \(0\)\
\-\ posterior\\ reversible\\ encephalopathy\\ syndrome\\ has\\ become\\ a\\ little\\ bit\\ of\\ a\\ misnomer\\,\\ because\\ the\\ lesions\\ are\\ not\\ limited\\ to\\ the\\ posterior\\ brain\\ \\(occipital\\ lobe\\)\\ and\\ the\\ lesions\\ are\\ not\\ always\\ reversible\\.\\ pmid\\:\\ 17885064\\ \ \(0\)\
\-\ in\\ the\\ original\\ reports\\,\\ a\\ unifying\\ theme\\ has\\ been\\ elevated\\ blood\\ pressure\\,\\ and\\ lack\\ of\\ other\\ causes\\ for\\ the\\ abnormalities\\.\\ \ \(0\)\
\-\ more\\ recent\\ reports\\ have\\ also\\ implicated\\ underlying\\ autoimmune\\ dysfunction\\ of\\ endothelial\\ cells\\,\\ causing\\ a\\ breakdown\\ in\\ the\\ blood\\-brain\\-barrier\\.\\ \\ pmid\\:\\ 20435835\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ reversible\\:\\ 0\\.41896645724380877\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.2862268098809209\ \(0\)\
\-\ posterior\\:\\ 0\\.23417770391181209\ \(0\)\
\-\ autoimmune\\:\\ 0\\.20265229729257517\ \(0\)\
\-\ pmid\\:\\ 0\\.1987984440852696\ \(0\)\
\-\ syndrome\\:\\ 0\\.16380696958688498\ \(0\)\
\-\ 17885064\\:\\ 0\\.1448442786993087\ \(0\)\
\-\ 20435835\\:\\ 0\\.1448442786993087\ \(0\)\
\-\ reports\\:\\ 0\\.14085929208331247\ \(0\)\
\-\ misnomer\\:\\ 0\\.13840644097343385\ \(0\)\
\-\ unifying\\:\\ 0\\.13840644097343385\ \(0\)\
\-\ theme\\:\\ 0\\.13840644097343385\ \(0\)\
\-\ the\\:\\ 0\\.1265067125102246\ \(0\)\
\-\ bit\\:\\ 0\\.1209630469632876\ \(0\)\
\-\ implicated\\:\\ 0\\.11777686559307918\ \(0\)\
\-\ endothelial\\:\\ 0\\.11394777609467735\ \(0\)\
\-\ brain\\:\\ 0\\.1129246390621885\ \(0\)\
\-\ breakdown\\:\\ 0\\.1128523306371199\ \(0\)\
\-\ pres\\:\\ 0\\.11182760984649445\ \(0\)\
\-\ obtunded\\:\\ 0\\.11086503262433156\ \(0\)\
\-\ blood\\:\\ 0\\.10520147200201682\ \(0\)\
\-\ lesions\\:\\ 0\\.10403300600629654\ \(0\)\
\-\ original\\:\\ 0\\.09613077281234796\ \(0\)\
\-\ lupus\\:\\ 0\\.09438421583634819\ \(0\)\
\-\ t2w\\:\\ 0\\.09137949542951135\ \(0\)\
\-\ encephalitis\\:\\ 0\\.09006654435865624\ \(0\)\
\-\ vasogenic\\:\\ 0\\.08908914897258667\ \(0\)\
\-\ little\\:\\ 0\\.08908914897258667\ \(0\)\
\-\ no\\:\\ 0\\.08835891061766742\ \(0\)\
\-\ dysfunction\\:\\ 0\\.08794637811047336\ \(0\)\
\-\ 49\\:\\ 0\\.08549882580025966\ \(0\)\
\-\ always\\:\\ 0\\.08549882580025966\ \(0\)\
\-\ stroke\\:\\ 0\\.08422793478439351\ \(0\)\
\-\ vasculitis\\:\\ 0\\.08405440670226294\ \(0\)\
\-\ viral\\:\\ 0\\.08354491930655765\ \(0\)\
\-\ has\\:\\ 0\\.0827412629003949\ \(0\)\
\-\ become\\:\\ 0\\.08037393914523992\ \(0\)\
\-\ restricted\\:\\ 0\\.0778483637715173\ \(0\)\
\-\ occipital\\:\\ 0\\.07750192832331003\ \(0\)\
\-\ lack\\:\\ 0\\.07750192832331003\ \(0\)\
\-\ flair\\:\\ 0\\.07705146799852393\ \(0\)\
\-\ diffusion\\:\\ 0\\.0762926640165345\ \(0\)\
\-\ lobes\\:\\ 0\\.07556847575923921\ \(0\)\
\-\ seizure\\:\\ 0\\.07536749001890905\ \(0\)\
\-\ and\\:\\ 0\\.07486234515625113\ \(0\)\
\-\ neurological\\:\\ 0\\.07439903979446964\ \(0\)\
\-\ causing\\:\\ 0\\.07439903979446964\ \(0\)\
\-\ underlying\\:\\ 0\\.07393610141936507\ \(0\)\
\-\ parietal\\:\\ 0\\.07313537739765551\ \(0\)\
\-\ limited\\:\\ 0\\.07229062172401365\ \(0\)\
\-\ not\\:\\ 0\\.07151130921543977\ \(0\)\
\-\ cells\\:\\ 0\\.06978441525964453\ \(0\)\
\-\ matter\\:\\ 0\\.06896297373542878\ \(0\)\
\-\ pressure\\:\\ 0\\.06896297373542878\ \(0\)\
\-\ are\\:\\ 0\\.06873587788075963\ \(0\)\
\-\ causes\\:\\ 0\\.06843804455642698\ \(0\)\
\-\ in\\:\\ 0\\.06759409128592153\ \(0\)\
\-\ abnormalities\\:\\ 0\\.06560787947989973\ \(0\)\
\-\ intensity\\:\\ 0\\.06431208232328182\ \(0\)\
\-\ effect\\:\\ 0\\.0635350386362727\ \(0\)\
\-\ signs\\:\\ 0\\.06329980971947476\ \(0\)\
\-\ because\\:\\ 0\\.06329980971947476\ \(0\)\
\-\ or\\:\\ 0\\.0630167429826569\ \(0\)\
\-\ elevated\\:\\ 0\\.061744109964491964\ \(0\)\
\-\ recent\\:\\ 0\\.06132625265213386\ \(0\)\
\-\ first\\:\\ 0\\.06112137675829324\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.060640198678169006\ \(0\)\
\-\ white\\:\\ 0\\.05975681195170362\ \(0\)\
\-\ frontal\\:\\ 0\\.05829453545432859\ \(0\)\
\-\ abnormal\\:\\ 0\\.05441441968338623\ \(0\)\
\-\ focal\\:\\ 0\\.05417605164805817\ \(0\)\
\-\ edema\\:\\ 0\\.054019104787216395\ \(0\)\
\-\ time\\:\\ 0\\.05368428362251003\ \(0\)\
\-\ with\\:\\ 0\\.05320536518432767\ \(0\)\
\-\ of\\:\\ 0\\.05317359397459842\ \(0\)\
\-\ been\\:\\ 0\\.05276824867807612\ \(0\)\
\-\ lobe\\:\\ 0\\.05234102124949828\ \(0\)\
\-\ signal\\:\\ 0\\.05134266801789171\ \(0\)\
\-\ more\\:\\ 0\\.049733692381206784\ \(0\)\
\-\ metastatic\\:\\ 0\\.04967418827106195\ \(0\)\
\-\ symptoms\\:\\ 0\\.049555844904758756\ \(0\)\
\-\ woman\\:\\ 0\\.047170171955846114\ \(0\)\
\-\ other\\:\\ 0\\.04703547200503415\ \(0\)\
\-\ have\\:\\ 0\\.04524566112419852\ \(0\)\
\-\ but\\:\\ 0\\.04478797485030741\ \(0\)\
\-\ presents\\:\\ 0\\.04356978702130767\ \(0\)\
\-\ also\\:\\ 0\\.04260245339744954\ \(0\)\
\-\ disease\\:\\ 0\\.038018890449479925\ \(0\)\
\-\ mass\\:\\ 0\\.03459607018496242\ \(0\)\
\-\ year\\:\\ 0\\.027912494300967695\ \(0\)\
\-\ for\\:\\ 0\\.02745166541296315\ \(0\)\
\-\ old\\:\\ 0\\.02680565667861273\ \(0\)\
\-\ to\\:\\ 0\\.02264281163394123\ \(0\)\
